{"id":"https://openalex.org/W7166166291","doi":"https://doi.org/10.1097/mop.0000000000001592","title":"Advanced therapies in management of pediatric inflammatory bowel disease","display_name":"Advanced therapies in management of pediatric inflammatory bowel disease","publication_year":2026,"publication_date":"2026-06-25","ids":{"openalex":"https://openalex.org/W7166166291","doi":"https://doi.org/10.1097/mop.0000000000001592","pmid":"https://pubmed.ncbi.nlm.nih.gov/42361097"},"language":"en","primary_location":{"id":"doi:10.1097/mop.0000000000001592","doi":"https://doi.org/10.1097/mop.0000000000001592","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mop.0000000000001592","pdf_url":null,"source":{"id":"https://openalex.org/S204673346","display_name":"Current Opinion in Pediatrics","issn_l":"1040-8703","issn":["1040-8703","1080-8116","1531-698X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Pediatrics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5123582782","display_name":"Justin Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297463080","display_name":"Children's Medical Center","ror":"https://ror.org/02ndk3y82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1297463080"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Williams","raw_affiliation_strings":["Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA","institution_ids":["https://openalex.org/I1297463080","https://openalex.org/I867280407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020774183","display_name":"Bhaskar Gurram","orcid":"https://orcid.org/0000-0003-3169-2225","observed_orcids":["https://orcid.org/0000-0003-3169-2225"]},"institutions":[{"id":"https://openalex.org/I1297463080","display_name":"Children's Medical Center","ror":"https://ror.org/02ndk3y82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1297463080"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bhaskar Gurram","raw_affiliation_strings":["Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA","to Bhaskar Gurram, MBBS, MD, 2350 N. Stemmons Freeway, Suite F4500, Dallas, TX 75207, USA. Tel: 214 456 8001; e-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA","institution_ids":["https://openalex.org/I1297463080","https://openalex.org/I867280407"]},{"raw_affiliation_string":"to Bhaskar Gurram, MBBS, MD, 2350 N. Stemmons Freeway, Suite F4500, Dallas, TX 75207, USA. Tel: 214 456 8001; e-mail: [email\u00a0protected]","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5020774183"],"corresponding_institution_ids":["https://openalex.org/I1297463080","https://openalex.org/I867280407"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.47769018,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"5","first_page":"493","last_page":"501"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-inflammatory-bowel-disease","display_name":"pediatric inflammatory bowel disease","score":1.0},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.9850000143051147},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":1.0},{"id":"https://openalex.org/keywords/vedolizumab","display_name":"vedolizumab","score":0.902999997138977},{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":1.0},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/dual-targeted-therapy","display_name":"dual-targeted therapy","score":0.9739999771118164},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.7450000047683716},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.75},{"id":"https://openalex.org/keywords/refractory-disease","display_name":"refractory disease","score":0.7670000195503235},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9610000252723694},{"id":"https://openalex.org/C2778975655","wikidata":"https://www.wikidata.org/wiki/Q420305","display_name":"Ustekinumab","level":4,"score":0.8392999768257141},{"id":"https://openalex.org/C2776207728","wikidata":"https://www.wikidata.org/wiki/Q7918002","display_name":"Vedolizumab","level":4,"score":0.8278999924659729},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.7469000220298767},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.6647999882698059},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6141999959945679},{"id":"https://openalex.org/C2911221801","wikidata":"https://www.wikidata.org/wiki/Q2742406","display_name":"Biologic Agents","level":3,"score":0.5551000237464905},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.5216000080108643},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5102999806404114},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5087000131607056},{"id":"https://openalex.org/C2780665704","wikidata":"https://www.wikidata.org/wiki/Q959298","display_name":"Intervention (counseling)","level":2,"score":0.4253000020980835},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.39910000562667847},{"id":"https://openalex.org/C2982889124","wikidata":"https://www.wikidata.org/wiki/Q107439039","display_name":"Disease management","level":4,"score":0.3433000147342682},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.34150001406669617},{"id":"https://openalex.org/C2776233030","wikidata":"https://www.wikidata.org/wiki/Q17149812","display_name":"Janus kinase inhibitor","level":4,"score":0.33899998664855957},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.30480000376701355},{"id":"https://openalex.org/C2777572184","wikidata":"https://www.wikidata.org/wiki/Q15749161","display_name":"Inflammatory Bowel Diseases","level":4,"score":0.3028999865055084},{"id":"https://openalex.org/C78780964","wikidata":"https://www.wikidata.org/wiki/Q7233193","display_name":"Position paper","level":2,"score":0.29760000109672546},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.29739999771118164},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2888999879360199},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2777999937534332},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.26930001378059387},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.2583000063896179},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.25690001249313354},{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.25380000472068787}],"mesh":[{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000075242","descriptor_name":"Janus Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003093","descriptor_name":"Colitis, Ulcerative","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005765","descriptor_name":"Gastrointestinal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015212","descriptor_name":"Inflammatory Bowel Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/mop.0000000000001592","doi":"https://doi.org/10.1097/mop.0000000000001592","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mop.0000000000001592","pdf_url":null,"source":{"id":"https://openalex.org/S204673346","display_name":"Current Opinion in Pediatrics","issn_l":"1040-8703","issn":["1040-8703","1080-8116","1531-698X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Pediatrics","raw_type":"journal-article"},{"id":"pmid:42361097","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42361097","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in pediatrics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W1658971169","https://openalex.org/W1981017999","https://openalex.org/W1996063338","https://openalex.org/W2000500639","https://openalex.org/W2009980852","https://openalex.org/W2013089847","https://openalex.org/W2027142766","https://openalex.org/W2035863637","https://openalex.org/W2043780895","https://openalex.org/W2064485014","https://openalex.org/W2136589391","https://openalex.org/W2147378461","https://openalex.org/W2171492921","https://openalex.org/W2279977120","https://openalex.org/W2587130863","https://openalex.org/W2587731986","https://openalex.org/W2593695507","https://openalex.org/W2725046187","https://openalex.org/W2758685767","https://openalex.org/W2768238274","https://openalex.org/W2781618914","https://openalex.org/W2790513522","https://openalex.org/W2800876436","https://openalex.org/W2807688850","https://openalex.org/W2841623998","https://openalex.org/W2949255324","https://openalex.org/W2994644048","https://openalex.org/W3092023159","https://openalex.org/W3097531917","https://openalex.org/W3137851134","https://openalex.org/W3155102575","https://openalex.org/W3157976196","https://openalex.org/W3165747682","https://openalex.org/W3175981068","https://openalex.org/W3202460246","https://openalex.org/W4220814394","https://openalex.org/W4220957505","https://openalex.org/W4304480265","https://openalex.org/W4310596889","https://openalex.org/W4313454798","https://openalex.org/W4362465092","https://openalex.org/W4365135578","https://openalex.org/W4379509178","https://openalex.org/W4396624624","https://openalex.org/W4398244364","https://openalex.org/W4399303906","https://openalex.org/W4404827972","https://openalex.org/W4406091847","https://openalex.org/W4406739516","https://openalex.org/W4407295961","https://openalex.org/W4410019431","https://openalex.org/W4416322485","https://openalex.org/W4416420669","https://openalex.org/W4416423854","https://openalex.org/W7119515219","https://openalex.org/W7129042913","https://openalex.org/W7129318268","https://openalex.org/W7133210576","https://openalex.org/W7138306155","https://openalex.org/W7141478854"],"related_works":[],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"Pediatric":[3],"inflammatory":[4],"bowel":[5],"disease":[6,21,83,164],"(PIBD)":[7],"has":[8],"a":[9,144],"rising":[10],"global":[11],"prevalence,":[12],"with":[13,141,151,162],"patients":[14,50,134,161],"often":[15],"demonstrating":[16],"more":[17],"aggressive":[18,149],"and":[19,56,60,84,91,99,112,171,182,197],"extensive":[20],"activity":[22],"compared":[23],"to":[24,30,40,61,155,192],"adult-onset":[25],"disease.":[26,124],"With":[27],"improved":[28,156,178],"access":[29],"therapeutic":[31,167],"agents":[32,76,111],"outside":[33],"of":[34,48,53,67,97,130,143,174,180],"the":[35,46,65,95,128],"anti-TNF-\u03b1":[36],"class,":[37],"we":[38],"seek":[39],"provide":[41],"an":[42],"updated":[43],"framework":[44],"for":[45,80,122,132,177],"management":[47],"PIBD":[49,133,160],"through":[51],"use":[52,66,96,129,142,173],"advanced":[54,152],"biologic":[55],"small":[57],"molecule":[58],"therapies":[59,153],"give":[62],"guidance":[63],"on":[64],"dual":[68],"targeted":[69],"therapy":[70,181],"(DTT).":[71],"RECENT":[72],"FINDINGS:":[73],"Although":[74],"anti-TNF":[75],"remain":[77],"first-line":[78],"options":[79],"moderate-to-severe":[81,163],"Crohn's":[82],"ulcerative":[85],"colitis,":[86],"emerging":[87],"pediatric":[88,188],"clinical":[89,157,184],"trial":[90],"real-world":[92],"data":[93,106],"support":[94],"vedolizumab":[98],"ustekinumab":[100],"as":[101],"second-line":[102],"therapies.":[103],"While":[104],"PIBD-specific":[105],"are":[107,190],"limited,":[108],"novel":[109,195],"anti-IL-23p19":[110,196],"oral":[113],"Janus":[114],"kinase":[115],"inhibitors":[116],"(JAKi)":[117],"have":[118],"shown":[119],"promising":[120],"results":[121],"refractory":[123],"Emerging":[125],"evidence":[126],"supports":[127],"DTT":[131,175],"who":[135],"do":[136],"not":[137],"achieve":[138],"remission":[139,185],"endpoints":[140],"single":[145],"agent.":[146],"SUMMARY:":[147],"Early":[148],"intervention":[150],"leads":[154],"outcomes":[158],"in":[159],"activity.":[165],"Proactive":[166],"drug":[168],"monitoring":[169],"(TDM)":[170],"strategic":[172],"allow":[176],"durability":[179],"better":[183],"rates.":[186],"Additional":[187],"studies":[189],"needed":[191],"properly":[193],"position":[194],"JAKi":[198],"agents.":[199]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2026-06-27T00:00:00"}